Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
This article shows the metabolic effects of semaglutide 2.4 mg in patients with obesity and diabetes
Thymosin Alpha-1 is currently not approved by the FDA and it is still being studied in ongoing clinical trials
Trends Biotechnol 16(1):3540 Hoy SM (2018) Patisiran: first global approval
Peptide Structure-Function Studies Serves as a model compound for examining how short peptide sequences influence cellular signaling and biochemical responses in laboratory environments
DSIP + GHK-Cu Investigated for combined recovery and restorative sleep-cycle support
Determination of oxidative stress level and some antioxidant activities in refractory epilepsy patients
US$ 27.21
US$ 29.10
US$ 23.91
